Using mass spectrometry‐based methods to understand amyloid formation and inhibition of alpha‐synuclein and amyloid beta
Mass Spectrometry Reviews · 2024-07 · 43 (4) · 782-825
DOI: 10.1002/mas.21814 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, 2024-07. Verfasst von Wesley J Wagner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Washington University in St. Louis, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Amyloid beta-Peptides, Mass Spectrometry, Amyloid. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Amyloid fibrils, insoluble β‐sheets structures that arise from protein misfolding, are associated with several neurodegenerative disorders. Many small molecules have been investigated to prevent amyloid fibrils from forming; however, there are currently no therapeutics to combat these diseases. Mass spectrometry (MS) is proving to be effective for studying the high order structure (HOS) of aggregating proteins and for determining structural changes accompanying protein–inhibitor interactions. When combined with native MS (nMS), gas‐phase ion mobility, protein footprinting, and chemical cross‐linking, MS can afford regional and sometimes amino acid spatial resolution of the aggregating protein. The spatial resolution is greater than typical low‐resolution spectroscopic, calorimetric, and the traditional ThT fluorescence methods used in amyloid research today. High‐resolution approaches can struggle when investigating protein aggregation, as the proteins exist as complex oligomeric mixtures of many sizes and several conformations or polymorphs. Thus, MS is positioned to complement both high‐ and low‐resolution approaches to studying amyloid fibril formation and protein–inhibitor interactions. This review covers basics in MS paired with ion mobility, continuous hydrogen‐deuterium exchange (continuous HDX), pulsed hydrogen‐deuterium exchange (pulsed HDX), fast photochemical oxidation of proteins (FPOP) and other irreversible labeling methods, and chemical cross‐linking. We then review the applications of these approaches to studying amyloid‐prone proteins with a focus on amyloid beta and alpha‐synuclein. Another focus is the determination of protein–inhibitor interactions. The expectation is that MS will bring new insights to amyloid formation and thereby play an important role to prevent their formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Washington University in St. Louis, St. Louis, Missouri, USA.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Wagner, W. J., & Gross, M. L. (2024). Using mass spectrometry‐based methods to understand amyloid formation and inhibition of alpha‐synuclein and amyloid beta. Mass Spectrometry Reviews. https://doi.org/10.1002/mas.21814
Vancouver
Wagner WJ, Gross ML. Using mass spectrometry‐based methods to understand amyloid formation and inhibition of alpha‐synuclein and amyloid beta. Mass Spectrometry Reviews. 2024. doi:10.1002/mas.21814
BibTeX
@article{Wagner2024,
author = {Wagner, Wesley J and Gross, Michael L},
title = {Using mass spectrometry‐based methods to understand amyloid formation and inhibition of alpha‐synuclein and amyloid beta},
journal = {Mass Spectrometry Reviews},
year = {2024},
doi = {10.1002/mas.21814}
}
EUVIMED